K Muth

505 total citations
20 papers, 369 citations indexed

About

K Muth is a scholar working on Epidemiology, Infectious Diseases and Virology. According to data from OpenAlex, K Muth has authored 20 papers receiving a total of 369 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 8 papers in Infectious Diseases and 4 papers in Virology. Recurrent topics in K Muth's work include HIV Research and Treatment (4 papers), Tuberculosis Research and Epidemiology (4 papers) and Pneumocystis jirovecii pneumonia detection and treatment (4 papers). K Muth is often cited by papers focused on HIV Research and Treatment (4 papers), Tuberculosis Research and Epidemiology (4 papers) and Pneumocystis jirovecii pneumonia detection and treatment (4 papers). K Muth collaborates with scholars based in United States and Canada. K Muth's co-authors include Lawrence Deyton, Richard Hafner, Joyce A. Korvick, Norman Markowitz, James D. Neaton, Roberta Luskin‐Hawk, Steven Wakefield, Cynthia A. Launer, David L. Cohn and Donald I. Abrams and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Neurology.

In The Last Decade

K Muth

19 papers receiving 351 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
K Muth United States	11	164	138	82	76	35	20	369
Roberta Luskin‐Hawk United States	8	270 1.6×	233 1.7×	131 1.6×	66 0.9×	11 0.3×	9	447
James Sampson United States	9	234 1.4×	144 1.0×	158 1.9×	65 0.9×	16 0.5×	12	500
JA Stone United Kingdom	9	233 1.4×	88 0.6×	140 1.7×	9 0.1×	21 0.6×	12	551
Danielle Richardson United States	11	120 0.7×	42 0.3×	62 0.8×	12 0.2×	35 1.0×	30	384
Simbarashe Zvada South Africa	9	169 1.0×	72 0.5×	39 0.5×	10 0.1×	18 0.5×	12	276
Larry Peiperl United States	9	76 0.5×	92 0.7×	55 0.7×	7 0.1×	7 0.2×	11	232
Craig A. Magaret United States	11	98 0.6×	51 0.4×	69 0.8×	14 0.2×	66 1.9×	28	371
Mohammed Janabi Tanzania	9	216 1.3×	81 0.6×	119 1.5×	4 0.1×	21 0.6×	15	412
F. Javier Vilar United Kingdom	12	156 1.0×	166 1.2×	100 1.2×	12 0.2×	14 0.4×	20	623
Laurence P. Skendzel United States	8	54 0.3×	145 1.1×	17 0.2×	34 0.4×	17 0.5×	19	364

Countries citing papers authored by K Muth

Since Specialization

Citations

This map shows the geographic impact of K Muth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K Muth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K Muth more than expected).

Fields of papers citing papers by K Muth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K Muth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K Muth. The network helps show where K Muth may publish in the future.

Co-authorship network of co-authors of K Muth

This figure shows the co-authorship network connecting the top 25 collaborators of K Muth. A scholar is included among the top collaborators of K Muth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K Muth. K Muth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Muth, K, Eunice Yu, Beverly Alston, & Jonas H. Ellenberg. (2001). The Closeout Process for a Clinical Trial Terminated Early for Lagging Enrollment and Inadequate Follow-up. Controlled Clinical Trials. 22(1). 49–55. 10 indexed citations

2.

Hafner, Richard, Clark B. Inderlied, Dolores M. Peterson, et al.. (1999). Correlation of Quantitative Bone Marrow and Blood Cultures in AIDS Patients with DisseminatedMycobacterium aviumComplex Infection. The Journal of Infectious Diseases. 180(2). 438–447. 15 indexed citations

3.

Alston, Beverly, Jonas H. Ellenberg, Harold C. Standiford, et al.. (1999). A Multicenter, Randomized, Controlled Trial of Three Preparations of Low-Dose Oral α-Interferon in HIV-Infected Patients With CD4+ Counts Between 50 and 350 cells/mm3. JAIDS Journal of Acquired Immune Deficiency Syndromes. 22(4). 348–348. 12 indexed citations

4.

Alston, Beverly, Jonas H. Ellenberg, Harold C. Standiford, et al.. (1999). A Multicenter, Randomized, Controlled Trial of Three Preparations of Low-Dose Oral α-Interferon in HIV-Infected Patients With CD4+ Counts Between 50 and 350 cells/mm3. JAIDS Journal of Acquired Immune Deficiency Syndromes. 22(4). 348–348. 11 indexed citations

5.

Hafner, Richard, David J. Wright, Nancy E. Dunlap, et al.. (1997). Early Bactericidal Activity of Isoniazid in Pulmonary Tuberculosis. American Journal of Respiratory and Critical Care Medicine. 156(3). 918–923. 34 indexed citations

6.

Rossi, Stephen J., T J Schroeder, K Muth, et al.. (1996). Serial monitoring of soluble interleukin-2 receptor as a rapid marker of cytomegalovirus infection and response to antiviral therapy.. PubMed. 10(1 Pt 1). 45–50. 5 indexed citations

7.

Gordin, Fred M., John P. Matts, Joyce A. Korvick, et al.. (1995). Two-Stage Tuberculin Skin Testing in Individuals with Human Immunodeficiency Virus Infection. American Journal of Respiratory and Critical Care Medicine. 151(3_Part_1). 805–808. 11 indexed citations

8.

Matts, John P., et al.. (1995). Two-Stage Tuberculin Skin Testing in Individuals with Human Immunodeficiency Virus Infection. Community Programs for Clinical Research on AIDS. American Journal of Respiratory and Critical Care Medicine. 151(3). 805–808. 3 indexed citations

9.

Abrams, Donald I., Anne I. Goldman, Cynthia A. Launer, et al.. (1994). A Comparative Trial of Didanosine or Zalcitabine after Treatment with Zidovudine in Patients with Human Immunodeficiency Virus Infection. New England Journal of Medicine. 330(10). 657–662. 150 indexed citations

10.

Jacobson, Mark Z., C. Lynn Besch, Carroll Child, et al.. (1994). Primary Prophylaxis with Pyrimethamine for Toxoplasmic Encephalitis in Patients with Advanced Human Immunodeficiency Virus Disease: Results of a Randomized Trial. The Journal of Infectious Diseases. 169(2). 384–394. 40 indexed citations

11.

Rossi, Stephen J., et al.. (1994). Soluble interleukin-2 receptor monitoring during bacterial and viral infections in liver transplant recipients: a comparative evaluation.. PubMed. 8(5). 479–84. 11 indexed citations

12.

Freedman, M. S., Jack P. Antel, K Muth, John L. Trotter, & Carl Yoshizawa. (1993). IL‐2 and MS. Neurology. 43(7). 1450–1450.

13.

Muth, K, et al.. (1993). Soluble interleukin-2 receptor levels in pediatric liver transplant recipients.. PubMed. 25(2). 1783–4. 3 indexed citations

14.

Jacobson, Mark Z., Carroll Child, C. Lynn Besch, et al.. (1992). Toxicity of clindamycin as prophylaxis for AIDS-associated toxoplasmic encephalitis. The Lancet. 339(8789). 333–334. 30 indexed citations

15.

Freedman, Mark S., K Muth, John L. Trotter, Carl Yoshizawa, & Jack P. Antel. (1992). Prospective serial analysis of interleukin‐2 and soluble interleukim‐2 receptor in relapsing‐remitting multiple sclerosis. Neurology. 42(8). 1596–1596. 11 indexed citations

16.

Jacobson, Mark Z., C. Lynn Besch, Carroll Child, et al.. (1991). Clinical programs for clinical research on AIDS: Description of a randomized prospective study of clindamycin versus pyrimethamine for prevention ofToxoplasma gondii infection. European Journal of Clinical Microbiology & Infectious Diseases. 10(3). 195–198. 4 indexed citations

17.

Muth, K, et al.. (1981). Filtrability of whole blood and erythrocyte suspensions under the influence of several anticoagulants.. PubMed. 11 Suppl 1. 109–16. 1 indexed citations

18.

Hübner, Martin, et al.. (1969). [Acylaminoalkylbenzolsulfonylaminopyrimidines as blood sugar decreasing substances].. PubMed. 19(8). Suppl:1346–50. 1 indexed citations

19.

Hübner, Martin, et al.. (1969). [Acylaminoalkylbenzolsulfonylsemicarbazides as blood sugar decreasing substances].. PubMed. 19(8). Suppl:1350–4. 2 indexed citations

20.

Muth, K, et al.. (1966). [A new highly-active oral antidiabetic].. PubMed. 16(12). 1640–1. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact